Type 2 Diabetes Research Study
Researchers at Pennington Biomedical Research Center are conducting a study to learn more about the effectiveness of WW, a virtual behavioral weight management program in people with type 2 diabetes.
Fast Facts
Diagnosed With Type 2 Diabetes
Have Obesity Or Overweight
Compensation Provided
Conducted in Baton Rouge, LA
Study Background
We want to determine the effectiveness of the WeightWatchers (WW) program, enhanced with continuous glucose monitoring, at reducing HbA1c% in patients with type 2 diabetes.
The Center for Disease Control and Prevention reports that approximately 1 in 10 Americans have diabetes, and that over 90% of that population has type 2 diabetes. For these Americans, finding the right balance between a healthy lifestyle and enjoying their favorite foods can be a challenge.
This mostly virtual program will last approximately 12 months, and will include 4 in-person visits to Pennington Biomedical Research Center in Baton Rouge, LA (1 screening visit, 1 baseline visit, and 2 study visits).
Participants will be randomly assigned (assigned by chance like flipping a coin) to one of two virtual study programs:
- Usual Care Group: Participants will be asked to continue their routine medical care, and will receive 1 virtual session with a dietitian or nutrition counselor. At the end of the study, participants in this group will also receive a voucher for 12 months of WW and 1 month of continuous glucose monitor (CGM) devices.
- WW Intervention Group: Participants will be asked to download the WW app for the 12-month weight management program. The program will include Virtual Workshops led by a WW coach, the WW app, and related online community resources. Participants will be asked to wear a CGM throughout the duration of the study.
Measurements at the study visits include height, weight, waist circumference, blood pressure, a blood sample for HbA1c, surveys, and continuous glucose monitoring.
Study Background
We want to determine the effectiveness of the WeightWatchers (WW) program, enhanced with continuous glucose monitoring, at reducing HbA1c% in patients with type 2 diabetes.
The Center for Disease Control and Prevention reports that approximately 1 in 10 Americans have diabetes, and that over 90% of that population has type 2 diabetes. For these Americans, finding the right balance between a healthy lifestyle and enjoying their favorite foods can be a challenge.
This mostly virtual program will last approximately 12 months, and will include 4 in-person visits to Pennington Biomedical Research Center in Baton Rouge, LA (1 screening visit, 1 baseline visit, and 2 study visits).
Participants will be randomly assigned (assigned by chance like flipping a coin) to one of two virtual study programs:
- Usual Care Group: Participants will be asked to continue their routine medical care, and will receive 1 virtual session with a dietitian or nutrition counselor. At the end of the study, participants in this group will also receive a voucher for 12 months of WW and 1 month of continuous glucose monitor (CGM) devices.
- WW Intervention Group: Participants will be asked to download the WW app for the 12-month weight management program. The program will include Virtual Workshops led by a WW coach, the WW app, and related online community resources. Participants will be asked to wear a CGM throughout the duration of the study.
Measurements at the study visits include height, weight, waist circumference, blood pressure, a blood sample for HbA1c, surveys, and continuous glucose monitoring.
Additional Information
For the many Americans with type 2 diabetes, finding the right balance between a healthy lifestyle and enjoying their favorite foods can be a challenge. We want to determine the effectiveness of the WeightWatchers (WW) program, enhanced with continuous glucose monitoring, at reducing HbA1c% in patients with type 2 diabetes.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
Ages 18-70
Diagnosed with type 2 diabetes
Have overweight or obesity
Access to a smartphone that can download the weight watchers app
Willing to wear a continuous glucose monitor for duration of the trial
The duration of this mostly virtual program will last approximately 12 months, and will include 4 in-person visits to Pennington Biomedical Research Center in Baton Rouge, LA:
- 1 screening visit
- 1 baseline visit
- 2 study visits)
Participants will be randomly assigned to one of two virtual study programs:
- Usual Care Group: Participants will be asked to continue their routine medical care, and will receive 1 virtual session with a dietitian or nutrition counselor.
- WW Intervention Group: Participants will be asked to download an app for the weight management program, and to wear a CGM throughout the duration of the study. Before or after the Month 6 and Month 12 visits, participants will also be asked to wear a 2nd CGM. The program will include Virtual Workshops, the intervention app, and related online community resources.
Measurements at the study visits include height, weight, waist circumference, blood pressure, a blood sample for HbA1c, surveys, and continuous glucose monitoring. At the end of this study, participants in the Usual Care Group will also receive a voucher for 12 months of WW and 1 month of continuous glucose monitor (CGM) devices.
As a participant, you can receive up to $225 for your time and effort.
There is no cost for you to participate in our research study.
